The ALTERNATE trial: assessing a biomarker driven strategy for the treatment of post-menopausal women with ER+/Her2− invasive breast cancer
- Citation:
- Chin Clin Oncol vol 4 (3) 34
- Year:
- 2015
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- No-Endpoint
- Analysis:
- Trial-Description-Only
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pmc-release
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- Yes
- Book Volume:
- 5
- Parents:
- None
- Children:
- None
- Pharmas:
- Grants:
- U24CA196171, U10CA180821, U10CA180882 , U10 CA180821, U10 CA077440, U10 CA180882, U24 CA196171, U10 CA180833
- Corr. Author:
- Authors:
- Vera Jean Suman Matthew J. Ellis Cynthia X. Ma
- Networks:
- Study
- Alliance-A011106
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords:
- Breast cancer, aromatase inhibitors (AIs), postmenopausal